Clinical characteristics and outcomes of the oldest old people with type 2 diabetes - perspective from a tertiary diabetes center in Thailand

被引:11
|
作者
Yotsapon, Thewjitcharoen [1 ]
Sirinate, Krittiyawong [1 ]
Ekgaluck, Wanothayaroj [1 ]
Somboon, Vongterapak [1 ]
Tawee, Anuntakulnatee [1 ]
Worawit, Kittipoom [1 ]
Soontaree, Nakasatien [1 ]
Thep, Himathongkam [1 ]
机构
[1] Theptarin Hosp, Diabet & Thyroid Ctr, Bangkok, Thailand
来源
BMC ENDOCRINE DISORDERS | 2016年 / 16卷
关键词
Oldest old; Type; 2; diabetes; Thailand; Deintensification; GLYCEMIC CONTROL; LACTIC-ACIDOSIS; MELLITUS; METAANALYSIS; ASSOCIATION; ADULTS; RATES; GOALS; RISK;
D O I
10.1186/s12902-016-0115-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Advance in medicine has led to an increase in life expectancy of elderly diabetic patients especially on the growing population called the "oldest old", those in their mid-80s upwards. The aim of this study is to describe clinical characteristics and outcomes of "oldest old" patients in a specialized diabetes center. Methods: A retrospective review was conducted on medical records of type 2 diabetes who were older than 85 years at Theptarin hospital from September 2014 to August 2015. Results: During the study period, there were 143 oldest old diabetic patients who visited our hospital regularly. Of the 133 active follow-up patients (median time of follow-up 15 years, range 1-30 years), 70.7 % was female, the mean age of onset was 68.3 +/- 11.5 years and duration of diabetes was 20.1 +/- 11.1 years. According to the Charlson co-morbidity index (CCI), 35.3 % of patients were classified as having severe co-morbidities. The mean A1C, blood pressure, LDL were 6.7 +/- 1.1 %, 132/65 mmHg and 80 +/- 29 mg/dl respectively. 66.9 % of patients had tight glycemic control (A1C <7 %) while 12.0 % had poor control (A1C >8 %). Oral hypoglycemic agent (OHA) dual therapy was the most common treatment (26.3 %) followed by OHA monotherapy (22.6 %), insulin alone (19.5 %), diet therapy alone (12.7 %), and insulin plus OHA (8.3 %). Hypoglycemia was found in 10.5 % of patients in previous 12 months. Diabetic retinopathy, chronic kidney disease, cardiovascular disease, and stroke were presented in 23.4, 54.9, 15.8, 18.0 % of patients, respectively. Among patients whose received diabetic medications and resulted in very low level of A1C (A1C less than 6.0 %), only 20.0 % underwent deintensification. Conclusions: Our results revealed that real-world clinical outcomes of extreme elderly diabetic patients were diverse and being too "aggressive" diabetes treatment with older patients did occur frequently. Decision making in older people with diabetes is complex as chronic co-morbidities are very common.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Insulin treatment of Type 2 diabetes: a clinical perspective
    Bloomgarden, Zachary
    Drexler, Andrew
    Handelsman, Yehuda
    JOURNAL OF DIABETES, 2010, 2 (02) : 65 - 66
  • [22] Parental Characteristics Associated With Outcomes in Youth With Type 2 Diabetes: Results From the TODAY Clinical Trial
    Weinstock, Ruth S.
    Trief, Paula M.
    El Ghormli, Laure
    Goland, Robin
    McKay, Siripoom
    Milaszewski, Kerry
    Preske, Jeff
    Willi, Steven
    Yasuda, Patrice M.
    DIABETES CARE, 2015, 38 (05) : 784 - 792
  • [23] Clinical predictors of liver and diabetes outcomes in cirrhotic patients with type 2 diabetes
    Grisanti, C.
    Asero, C.
    Licata, A.
    Russo, G.
    Giandalia, A.
    Pitrone, C.
    Filomia, R.
    Caccamo, G.
    Saitta, C.
    Chianetta, R.
    Rizzo, A.
    Citarella, R.
    Giannitrapani, L.
    Caspanello, A. R.
    Raimondo, G.
    Cacciola, I.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S72 - S72
  • [24] A Review of Cardiovascular Outcomes in the Treatment of People with Type 2 Diabetes
    George Dailey
    Edward Wang
    Diabetes Therapy, 2014, 5 : 385 - 402
  • [25] Characteristics associated with polypharmacy in people with type 2 diabetes: the Dutch Diabetes Pearl cohort
    van Oort, S.
    Rutters, F.
    Warle-van Herwaarden, M. F.
    Schram, M. T.
    Stehouwer, C. D.
    Tack, C. J.
    Abbink, E. J.
    Wolffenbuttel, B. H.
    van der Klauw, M. M.
    DeVries, J. H.
    Siegelaar, S. E.
    Sijbrands, E. J.
    Ozcan, B.
    de Valk, H. W.
    Silvius, B.
    Schroijen, M. A.
    Jazet, I. M.
    van Ballegooijen, A. J.
    Beulens, J. W. J.
    Elders, P. J.
    Kramers, C.
    DIABETIC MEDICINE, 2021, 38 (04)
  • [26] Characteristics and outcome of type 2 diabetes in urban Aboriginal people: the Fremantle Diabetes Study
    Davis, T. M. E.
    McAullay, D.
    Davis, W. A.
    Bruce, D. G.
    INTERNAL MEDICINE JOURNAL, 2007, 37 (01) : 59 - 63
  • [27] A Review of Cardiovascular Outcomes in the Treatment of People with Type 2 Diabetes
    Dailey, George
    Wang, Edward
    DIABETES THERAPY, 2014, 5 (02) : 385 - 402
  • [28] Assessing Cardiovascular Target Attainment in Type 2 Diabetes Mellitus Patients in Tertiary Diabetes Center in Romania
    Salmen, Teodor
    Pietrosel, Valeria-Anca
    Reurean-Pintilei, Delia
    Iancu, Mihaela Adela
    Cimpeanu, Radu Cristian
    Bica, Ioana-Cristina
    Dumitriu-Stan, Roxana-Ioana
    Potcovaru, Claudia-Gabriela
    Salmen, Bianca-Margareta
    Diaconu, Camelia-Cristina
    Cretoiu, Sanda Maria
    Stoian, Anca Pantea
    PHARMACEUTICALS, 2024, 17 (09)
  • [29] Pharmacological treatment changes in 4.143 patients with dysregulated type 2 diabetes referred to a tertiary diabetes center
    Safai, N.
    Ridderstrale, M.
    DIABETOLOGIA, 2015, 58 : S187 - S187
  • [30] Clinical Characteristics and Outcomes of Type 2 Diabetes and patients Infected with COVID-19
    Bouchareb, Somaya
    Baili, Hassene
    Touil, Imen
    Brahem, Yosra
    Souhir, Kessisa
    Ayeb, Jihene
    Boudawara, Nadia Keskes
    Kneni, Jalel
    Boussoffara, Leila
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58